Legal & General Group PLC Pulse Biosciences, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 2,240 shares of PLSE stock, worth $38,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,240
Previous 1,448 54.7%
Holding current value
$38,528
Previous $12,000 108.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$6.69 - $14.54 $5,298 - $11,515
792 Added 54.7%
2,240 $25,000
Q4 2023

Feb 15, 2024
SELL
$3.85 - $12.84 $411 - $1,373
-107 Reduced 6.88%
1,448 $17,000
Q2 2023

Aug 14, 2023
BUY
$3.67 - $8.64 $5,706 - $13,435
1,555 New
1,555 $11,000
Q2 2022

Aug 22, 2022
SELL
$1.48 - $4.28 $2,271 - $6,569
-1,535 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.21 - $14.79 $349 - $1,227
83 Added 5.72%
1,535 $7,000
Q3 2021

Nov 15, 2021
SELL
$17.25 - $26.63 $1,138 - $1,757
-66 Reduced 4.35%
1,452 $31,000
Q1 2021

May 17, 2021
SELL
$22.43 - $44.27 $3,700 - $7,304
-165 Reduced 9.8%
1,518 $36,000
Q3 2020

Nov 13, 2020
SELL
$9.27 - $13.14 $4,013 - $5,689
-433 Reduced 20.46%
1,683 $20,000
Q2 2020

Aug 14, 2020
BUY
$6.23 - $13.09 $2,236 - $4,699
359 Added 20.43%
2,116 $22,000
Q1 2020

May 14, 2020
SELL
$5.23 - $15.2 $2,227 - $6,475
-426 Reduced 19.51%
1,757 $13,000
Q4 2019

Feb 13, 2020
BUY
$12.58 - $15.97 $4,956 - $6,292
394 Added 22.02%
2,183 $29,000
Q2 2018

Aug 10, 2018
BUY
$14.04 - $20.28 $673 - $973
48 Added 2.76%
1,789 $27,000
Q1 2018

May 17, 2018
SELL
$12.67 - $24.69 $7,323 - $14,270
-578 Reduced 24.92%
1,741 $24,000
Q4 2017

Feb 13, 2018
BUY
$18.81 - $30.33 $43,620 - $70,335
2,319
2,319 $55,000

Others Institutions Holding PLSE

# of Institutions
60
Shares Held
4.78M
Call Options Held
138K
Put Options Held
96.2K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $639M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email